Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03249389Completed
Open-label, single-arm trial, sponsored by Institut du Cancer de Montpellier. Primary endpoint: Percentage of occurrence of a hypercalciuria at 1 year. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03249389.